Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical significance of checkpoint regulator “Programmed death ligand-1 (PD-L1)” expression in meningioma: review of the current status
Shirin Karimi, Sheila Mansouri, Farshad Nassiri, et al.
Journal of Neuro-Oncology (2021) Vol. 151, Iss. 3, pp. 443-449
Open Access | Times Cited: 18

Showing 18 citing articles:

Dual-sgRNA CRISPR/Cas9 knockout of PD-L1 in human U87 glioblastoma tumor cells inhibits proliferation, invasion, and tumor-associated macrophage polarization
Javier Fierro, Jake DiPasquale, Joshua Perez, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 30
Chemotherapy and targeted therapies for meningiomas: what is the evidence?
Thomas Graillon, Émeline Tabouret, Olivier Chinot
Current Opinion in Neurology (2021) Vol. 34, Iss. 6, pp. 857-867
Closed Access | Times Cited: 23
Meningioma in the elderly
Michael Amoo, Jack Henry, Michael Farrell, et al.
Neuro-Oncology Advances (2023) Vol. 5, Iss. Supplement_1, pp. i13-i25
Open Access | Times Cited: 10
Clinical Significance of Molecular Alterations and Systemic Therapy for Meningiomas: Where Do We Stand?
Alessia Pellerino, Francesco Bruno, Rosa Palmiero, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2256-2256
Open Access | Times Cited: 11
Advances in Molecular Biological and Translational Studies in World Health Organization Grades 2 and 3 Meningiomas: A Literature Review
Atsushi Okano, Satoru Miyawaki, Yu Teranishi, et al.
Neurologia medico-chirurgica (2022) Vol. 62, Iss. 8, pp. 347-360
Open Access | Times Cited: 9
Innovative treatments for meningiomas
Thomas Graillon, Émeline Tabouret, Betty Salgues, et al.
Revue Neurologique (2023) Vol. 179, Iss. 5, pp. 449-463
Open Access | Times Cited: 5
Domestic Animal Models of Central Nervous System Tumors: Focus on Meningiomas
Michele Tomanelli, Tullio Florio, Gabriela Coronel Vargas, et al.
Life (2023) Vol. 13, Iss. 12, pp. 2284-2284
Open Access | Times Cited: 4
Volumetric growth rate of incidentally found meningiomas on immunotherapy
Assaf Berger, Reed Mullen, Kenneth Bernstein, et al.
Journal of Neuro-Oncology (2024) Vol. 166, Iss. 2, pp. 303-307
Closed Access | Times Cited: 1
Hsa_circ_0004872 mitigates proliferation, metastasis and immune escape of meningioma cells by suppressing PD-L1
K. Chen, Zhengming Huang, Changsheng Liu, et al.
Metabolic Brain Disease (2024) Vol. 39, Iss. 5, pp. 895-907
Open Access | Times Cited: 1
MRI features and tumor-infiltrating CD8 + T cells-based nomogram for predicting meningioma recurrence risk
Tao Han, Xianwang Liu, Changyou Long, et al.
Cancer Imaging (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Current experimental therapies for atypical and malignant meningiomas
Andres M. Corona, Long Di, Ashish H. Shah, et al.
Journal of Neuro-Oncology (2021) Vol. 153, Iss. 2, pp. 203-210
Closed Access | Times Cited: 6
Rethinking immunotherapy in meningiomas
Masaki Terabe, Jing Wu
Neuro-Oncology (2021) Vol. 23, Iss. 11, pp. 1812-1813
Open Access | Times Cited: 6
Investigation of the status of immune checkpoint molecules (PD-L1 and PD-1) in meningiomas by immunohistochemistry
İsmail Sayğın, Emel Çakır, Seher Nazlı Kazaz, et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2024) Vol. 54, Iss. 4, pp. 735-743
Open Access
Biomolecular-Related Medical Therapy for Meningiomas
Alessia Pellerino, Francesco Bruno, Edoardo Pronello, et al.
(2024), pp. 177-185
Closed Access
Radiosurgery for Intracranial Meningiomas: A Review of Anatomical Challenges and an Update on the Evidence
Matthew Goldman, Bin S. Teh, Simon S. Lo, et al.
Cancers (2024) Vol. 17, Iss. 1, pp. 45-45
Open Access
Case Report: Recurrent meningioma with multiple metastases
Juyue Zhou, Zhonghai Du
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1
Lymphoplasmacyte-rich meningioma with hematologic signs and PD-L1 over-expression
Gabriele Gaggero, Michela Campora, Davide Taietti, et al.
Autopsy and Case Reports (2022) Vol. 12, pp. e2021394-e2021394
Open Access | Times Cited: 2
Increased expression of leucine‐rich α‐2 glycoprotein 1 as a predictive biomarker of favorable progression‐free survival in meningioma
Mayuko Moritsubo, Takuya Furuta, Junko Miyoshi, et al.
Neuropathology (2023) Vol. 44, Iss. 2, pp. 96-103
Open Access
Page 1

Scroll to top